Update on the New ANA Classification System

Keck School of Medicine of USC

E. Taylor-Albert

Challenges of Prevention and Treatment of COVID-19 in the Immunocomp…

Cleveland Clinic Rheumatology

C. Calabrese

Our Approach to Autoimmune Disease Associated TMA

USTMA - The United States Thrombotic Microangiopathy Consortium

B. Dixon, C. Nester, M. Ahmed

Autoimmune-Associated TMA Case Discussion: Patient With SLE and MPGN…

USTMA - The United States Thrombotic Microangiopathy Consortium

M. Ahmed, B. Dixon, C. Nester

Vaccines in Immunocompromised Patients

University Hospitals

N. Singer

RheumNow News Highlights: 11 Agents That Cause Arthritis, Lupus - Te…

RheumNow

J. Cush

Dermatology-Rheumatology Grand Rounds: The Whole Is Greater Than the…

University of Colorado Department of Medicine

E. Wallace, J. Zell

Medical Therapy Related Complications in IBD

Cedars Sinai

M. Long

Antiphospholipid Syndrome (APS): Why Doesn't the APS Classification …

Michelle Petri

RheumNow December Update: Indications Awaiting

RheumNow

J. Cush

2022 Clinical Pearls in Pediatric Rheumatology for the Primary Care …

UChicago Medicine

J. Mcdonald, C. Edens, M. Tesher, L. Wagner-Weiner, C. Zic

Best of EULAR 2021: RheumNow Conference Highlights

RheumNow

J. Cush

Evaluation of SARS-CoV-2 Vaccine Response in a Multi-Racial/Ethnic C…

ACR Convergence 2021 Coverage

R. Fernandez Ruiz

Autoimmunity and COVID-19: The New Horizon

Cleveland Clinic Rheumatology

J. Scott Knight

2021 Update on LN, RA & COVID-19: Is Voclosporin a New Big Addition …

RheumNow

J. Cush

RheumNow (July) Update on OA, RA & PsA: Is OA Associated With Higher…

RheumNow

J. Cush

RheumNow February Update on Systemic Sclerosis, IBD & Pregnancy Risk…

RheumNow

J. Cush

New and Emerging Treatments of Cutaneous Lupus

Cleveland Clinic Rheumatology

J. Merola

Lessons in Autoimmunity from the World of Primary Immunodeficiency D…

Cleveland Clinic Rheumatology

T. Torgerson

Advances in SLE and Vasculitis

Cleveland Clinic Rheumatology

G. Silverman